Balyasny Asset Management
3 rounds tracked since 28 April 2026.
- Rounds
- 3
- Led
- 1
- Capital in these rounds
- $293M
Sectors
Countries
Rounds
- Soufflé TherapeuticsDevelops RNA therapies for serious diseases and healthier aging $135MSeries B · 13 Oct
- Oak Hill BioLeadAcquires and develops rare disease drugs that big pharma has deprioritized. $32.5MSeries A · 1 Jun
- Coultreon BiopharmaDevelops therapies advancing an immunology drug pipeline. $125MSeries A · 28 Apr
Often invests with
The Daily Raise
The day's rounds in your inbox each morning.
Subscribe to The Daily Raise